StoneX
SNEX
$115.85
-14.45%
StoneX Group Inc. is a global brokerage and financial services firm operating in the capital markets industry, providing execution, OTC/market-making, advisory, payment solutions, market intelligence, physical trading, and clearing services across four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. The company is a significant player in global financial markets, particularly known for its deep expertise in commodities and foreign exchange, serving a diverse client base that includes governments, banks, brokers, and institutional investors across the Americas, Europe, the Middle East, and Asia. The current investor narrative is focused on the company's aggressive growth trajectory, evidenced by its recent strategic acquisition to expand its payments segment capabilities, and its ability to capitalize on volatile market conditions to drive substantial revenue expansion, as reflected in its latest quarterly results.…
SNEX
StoneX
$115.85
Related headlines
Investment Opinion: Should I buy SNEX Today?
Rating: Hold. The core thesis is that SNEX's explosive growth and strong fundamentals are compelling, but these are largely priced in at current peak valuation levels, creating an unfavorable risk/reward balance for new capital.
Supporting evidence includes the stock's 134% one-year gain, a forward P/E of 20.64x that prices in continued growth, and a P/B ratio of 2.01x at the top of its historical range. While revenue growth of 39.7% YoY is exceptional and free cash flow generation of $3.55B is robust, the net margin of 0.23% highlights the business model's profitability constraints. The lack of a broad analyst consensus and target price further clouds the near-term valuation anchor.
The biggest risks are margin stagnation despite growth and a valuation reversion from current highs. This Hold rating would upgrade to a Buy if the PE multiple compressed meaningfully below 15x on sustained earnings growth, or if margins showed clear structural improvement above 0.5%. It would downgrade to a Sell if revenue growth decelerated sharply below 15% or if debt levels increased unsustainably. Relative to its own history and the low-margin nature of its business, the stock appears fairly valued to slightly overvalued at current levels.
Sign up to view all
SNEX 12-Month Price Forecast
The outlook for SNEX is one of consolidation after a meteoric rise. The fundamentals are strong, with robust cash flow and impressive top-line growth, but the valuation now reflects much of this success. The base case of moderated growth and stable margins is most probable. The stance would upgrade to bullish on evidence of sustainable margin expansion or a pullback that improves the risk/reward profile. It would turn bearish if the next quarterly report shows significant growth deceleration or margin pressure, confirming the bear case narrative.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on StoneX's 12-month outlook, with a consensus price target around $150.60 and implied upside of +30.0% versus the current price.
Average Target
$150.60
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$93 - $151
Analyst target range
Analyst coverage for StoneX is extremely limited, with only one analyst providing estimates according to the available data. This single analyst estimates EPS of $6.61 and revenue of $5.79 billion for the upcoming period. The lack of a broad consensus rating, target price, or buy/hold/sell distribution indicates insufficient analyst coverage to gauge institutional sentiment meaningfully. The implied upside or downside from a consensus target cannot be calculated due to this data gap. The implications of minimal analyst coverage are significant; it typically denotes a small-to-mid-cap stock that flies under the radar of major Wall Street firms, which can lead to higher volatility and less efficient price discovery. The wide target range or the absence of one suggests high uncertainty and a lack of established valuation benchmarks, making the stock more susceptible to sharp moves on company-specific news. The recent institutional rating from Jefferies in February 2026 was a reiteration of a 'Buy' rating, but with only one recent action, it's difficult to identify a trend. The scarcity of coverage means investors must rely more heavily on their own fundamental and technical analysis, as the stock may not benefit from the stabilizing influence and promotional cycles of sustained Wall Street attention.
Bulls vs Bears: SNEX Investment Factors
The bull case, supported by explosive 39.7% revenue growth, strong cash flow, and powerful technical momentum, currently holds stronger evidence. However, the bear case presents substantial risks centered on razor-thin margins, high leverage, and a valuation that has already re-rated significantly. The single most important tension in the investment debate is whether the company's aggressive growth and scaling can sustainably improve its ultra-low 0.23% net margin to justify its elevated valuation multiples, or if the high-volume, low-margin business model will cap profitability and trigger a multiple compression as growth potentially normalizes.
Bullish
- Explosive Revenue Growth: Q1 2026 revenue surged 39.72% YoY to $39.03 billion, accelerating from a multi-quarter trend. This growth, driven by core physical trading, significantly outpaces typical financial services firms and demonstrates successful market penetration.
- Strong Profitability & Cash Flow: Net income jumped sequentially from $85.7M to $139M in Q1 2026, showing operating leverage. The company generates substantial free cash flow ($3.55B TTM), providing internal funding for growth and debt service.
- Powerful Technical Momentum: The stock is up 134.27% over the past year and 75.19% over three months, decisively breaking out from consolidation. It exhibits strong relative strength (+22.69% vs. S&P 500 over one month) while maintaining a low beta of 0.66, suggesting a stable, fundamentally-driven ascent.
- Attractive Valuation on Sales/Assets: The stock trades at a Price-to-Sales ratio of 0.036 and a Price-to-Book ratio of 2.01, which are low relative to its growth. The trailing P/E of 16.21x appears modest for a company growing revenue at nearly 40%.
Bearish
- Extremely Thin Profit Margins: The business model is inherently low-margin, with a Q1 2026 net margin of just 0.23% and a gross margin of 2.29%. This makes earnings highly sensitive to small changes in revenue or costs, limiting bottom-line leverage.
- High Financial Leverage: The company carries a debt-to-equity ratio of 7.79, which is elevated and typical for a capital-intensive intermediary. While manageable with strong cash flow, this leverage amplifies financial risk in a downturn or period of rising interest rates.
- Trading at Peak Valuation & Price: The stock trades at 97% of its 52-week high ($141.99) and its P/B of 2.01x is at the top of its recent historical range (0.83x - 2.01x). This suggests much of the growth story is priced in, leaving little room for error and increasing downside risk.
- Minimal Analyst Coverage & Visibility: Only one analyst provides estimates, indicating the stock flies under the radar of major institutions. This leads to less efficient price discovery, higher volatility, and a lack of consensus benchmarks for valuation and growth.
SNEX Technical Analysis
StoneX is in a powerful, sustained uptrend, with the stock price surging 134.27% over the past year and trading at approximately 97% of its 52-week high of $141.99, positioning it near peak momentum levels. The stock's current price of $137.28 is significantly above its 52-week low of $53.53, indicating strong bullish sentiment, though this proximity to all-time highs also suggests potential for overextension and profit-taking. Recent momentum has been exceptionally strong, with the stock up 20.52% over the past month and 75.19% over the past three months, significantly outpacing the broader market, as evidenced by a relative strength of +22.69% versus the S&P 500 over one month. This acceleration from the longer-term trend suggests positive catalysts are actively driving the stock higher, with the price action showing a decisive breakout from previous consolidation patterns. The stock faces immediate technical resistance near its 52-week high of $141.99, a break above which could signal a continuation of the bullish trend towards new highs. On the downside, the 52-week low of $53.53 provides a distant but critical long-term support level, though more immediate support likely resides around the $120-$130 range where recent consolidation occurred. The stock exhibits a beta of 0.66, indicating it is approximately 34% less volatile than the broader market (SPY), which is notable given its explosive price appreciation and suggests the moves are driven by fundamental re-rating rather than speculative frenzy. This low beta relative to its performance implies a more stable ascent, but a breakdown below the $120 level could signal a significant trend reversal and test of deeper support. Volatility, as measured by the maximum drawdown of -20.91% over the period, has been contained relative to the magnitude of gains, supporting the thesis of a steady uptrend. The stock's low beta characteristic is crucial for risk management, suggesting that while the absolute gains are large, the stock's movements are less correlated with general market swings, potentially offering a diversification benefit. However, trading at 97% of its 52-week high leaves little margin for error, and any failure to break above the $142 resistance could lead to a sharp pullback as momentum wanes. The combination of high relative strength, low beta, and proximity to all-time highs creates a complex technical picture of strong momentum within a historically less volatile framework.
Beta
0.66
0.66x market volatility
Max Drawdown
-20.9%
Largest decline past year
52-Week Range
$54-$142
Price range past year
Annual Return
+90.2%
Cumulative gain past year
| Period | SNEX Return | S&P 500 |
|---|---|---|
| 1m | +2.2% | -2.0% |
| 3m | +43.6% | +13.9% |
| 6m | +82.7% | +8.7% |
| 1y | +90.2% | +20.5% |
| ytd | +78.5% | +8.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SNEX Fundamental Analysis
StoneX's revenue trajectory is explosive, with Q1 2026 revenue reaching $39.03 billion, representing a year-over-year growth of 39.72% from the $27.94 billion reported in Q1 2025. This acceleration is part of a multi-quarter trend of robust top-line expansion, driven primarily by its core physical trading operations, as evidenced by the 'Precious Metals Trading' segment contributing $35.68 billion in the latest period. The company's revenue mix is heavily weighted towards its commercial and institutional trading activities, which have benefited from heightened market volatility and client activity. This growth rate significantly outpaces typical financial services firms and underscores the company's successful scaling and market penetration. Profitability metrics show the company is solidly profitable, with Q1 2026 net income of $139 million and a trailing twelve-month free cash flow of $3.55 billion. However, its net margin remains razor-thin at 0.23%, and its gross margin for the quarter was 2.29%, which is characteristic of a high-volume, low-margin brokerage and trading business model. The quarterly net income of $139 million marks a substantial sequential increase from $85.7 million in the prior quarter (Q4 2025), indicating margin expansion and operating leverage. The operating margin for Q1 2026 was 1.74%, showing improvement in operational efficiency despite the inherently low-margin nature of its core transactions. The balance sheet reveals a highly leveraged capital structure, with a debt-to-equity ratio of 7.79, which is elevated and typical for a capital-intensive financial intermediary that utilizes significant leverage to fund trading activities. Despite this leverage, the company maintains a healthy current ratio of 1.57, indicating sufficient short-term liquidity to meet obligations. The return on equity (ROE) of 12.87% is respectable and reflects efficient use of shareholder capital, while the trailing free cash flow of $3.55 billion provides substantial internal funding for growth and debt service. The combination of strong cash generation and high leverage suggests the company is aggressively using debt to fuel its expansion, which amplifies returns but also increases financial risk in a downturn.
Quarterly Revenue
$39.0B
2025-12
Revenue YoY Growth
+0.39%
YoY Comparison
Gross Margin
+0.02%
Latest Quarter
Free Cash Flow
$3.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SNEX Overvalued?
Given StoneX's positive net income of $139 million in the latest quarter, the primary valuation metric selected is the Price-to-Earnings (P/E) ratio. The stock trades at a trailing P/E of 16.21x and a forward P/E of 20.64x based on analyst estimates. The forward P/E being higher than the trailing multiple suggests the market is pricing in expectations for continued, albeit potentially slower, earnings growth in the coming year. Compared to typical financial services or capital markets peers, a trailing P/E of 16.21x appears modest, especially considering the company's explosive revenue growth of nearly 40% YoY. The Price-to-Sales (P/S) ratio is exceptionally low at 0.036, and the Price-to-Book (P/B) ratio is 2.01, both of which suggest the market is valuing the stock based on its asset and sales base rather than its current profitability, which is thin. The EV/EBITDA of 10.91x provides a more normalized view of operating cash flow generation and appears reasonable for a growing financial intermediary. Historically, the stock's own valuation has expanded significantly with its price surge. For instance, its P/E ratio has risen from the 5-6x range seen in late 2024 and early 2025 to the current 16.21x, indicating the market has re-rated the stock upwards as growth materialized. The current P/B of 2.01x is also near the higher end of its recent historical range, which has fluctuated between approximately 0.83x and 2.01x over the past few years. Trading near the top of its own historical valuation bands suggests the market has already priced in a significant portion of the growth and margin improvement story, leaving less room for multiple expansion and increasing sensitivity to any earnings disappointment.
PE
16.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 4x~29x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. StoneX operates with extremely thin margins (0.23% net margin) in a capital-intensive business, making earnings highly sensitive to operational slippage. Its high debt-to-equity ratio of 7.79, while typical for the industry, significantly amplifies financial risk; a downturn in trading volumes or a spike in funding costs could pressure profitability. Furthermore, revenue concentration in physical trading (e.g., $35.68B from Precious Metals in Q1) creates dependency on specific commodity markets and client activity levels, introducing earnings volatility.
Market & Competitive Risks are elevated due to valuation and external factors. The stock trades at the top of its own historical valuation range (P/B of 2.01x) after a 134% surge, creating compression risk if growth decelerates. Its revenue model is inherently tied to market volatility; a sustained period of calm could sharply reduce volumes. While the low beta of 0.66 suggests lower market correlation, the stock's recent performance makes it susceptible to profit-taking and sector rotation away from high-momentum names. Limited analyst coverage exacerbates these risks by reducing visibility and stabilizing institutional interest.
Worst-Case Scenario involves a perfect storm of declining market volatility, rising interest rates, and an earnings miss. This could trigger a severe de-rating as the growth narrative unravels, leading to simultaneous margin compression and multiple contraction. The realistic downside could see the stock retreat towards its 52-week low of $53.53, representing a potential loss of approximately -61% from the current price of $137.28. A more immediate, severe pullback could test the -20.91% maximum drawdown level, implying a drop to around $108.60.
FAQ
The key risks are, in order of severity: 1) Financial Risk: High leverage (Debt/Equity of 7.79) amplifies downside in a downturn. 2) Profitability Risk: Ultra-thin net margins (0.23%) limit earnings power and make results volatile. 3) Market Dependency Risk: Revenue is tied to trading volumes, which depend on sustained market volatility. 4) Valuation & Sentiment Risk: Trading at 97% of its 52-week high with minimal analyst coverage makes the stock prone to sharp corrections if momentum wanes or growth disappoints.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock consolidating between $125 and $145 as growth moderates but remains strong. The Bull Case (25% probability) targets $160-$180 on sustained high growth and margin expansion. The Bear Case (20% probability) warns of a correction to $85-$110 if growth stalls and multiples contract. The most likely outcome is the Base Case, predicated on revenue growth decelerating to a sustainable 20-25% range while margins hold steady.
SNEX appears fairly valued to slightly overvalued relative to its own history. Its Price-to-Book ratio of 2.01x is at the top of its recent historical range (0.83x - 2.01x), and its forward P/E of 20.64x prices in continued growth. While the ultra-low Price-to-Sales ratio of 0.036 seems cheap, it reflects the business's razor-thin margins. The valuation implies the market expects sustained high revenue growth and eventual margin expansion. If those expectations are not met, the stock is vulnerable to multiple compression.
SNEX is a Hold, not a compelling buy at current levels. While the company exhibits explosive revenue growth (39.7% YoY) and strong free cash flow ($3.55B), the stock has already surged 134% in a year and trades at peak valuation multiples (P/B 2.01x). The risk/reward is balanced to slightly unfavorable for new capital. It could be a good buy for growth-oriented investors on a meaningful pullback (e.g., towards $120) or upon clear evidence of structural margin improvement from the current 0.23% net margin.
SNEX is more suitable for a medium-to-long-term investment horizon of 2-3 years, not short-term trading. While the stock has shown high momentum, its low beta of 0.66 suggests it is less correlated with daily market swings, reducing its appeal for short-term traders. The investment thesis hinges on the company's ability to scale and improve profitability over time, which is a multi-year story. The lack of a dividend also makes it purely a capital appreciation play. Investors should be prepared for volatility but have a horizon that allows the growth narrative to play out.